Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane for Lung Cancer Chemoprevention in Former Smokers
NCT03232138Phase 2Completed
- Start
- Jan 2018
- Primary completion
- Feb 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulforaphane in lung cancer. Started Jan 2018; status: completed.
02
Drugs
sulforaphane
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT03232138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232138.